↓ Skip to main content

Signatures of immune reprogramming in anti-CD52 therapy of MS: markers for risk stratification and treatment response

Overview of attention for article published in Neurological Research and Practice, December 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
14 Mendeley